Hypertension Clinical Trial
Official title:
Using a Telemedicine System to Promote Patient Care Among Underserved Individuals
We have established a Telemedicine System for chronic disease management. Based on a
personal health record, we have successfully used this system in diverse populations, in
over 600 patients, and in multiple disease states (heart failure, CVD risk reduction,
gestational diabetes). In this proposal, we will enhance this Telemedicine system to support
patient centered care (PCC) by increasing access, incorporating hypertension treatment
guideline, quality measures, automating reminders and feedback for both patients and health
care providers.
Inner-city, primarily African-American patients (N=252) with uncontrolled hypertension
(BP<140/90 mmHg) and who are followed by primary care physicians will be randomized to
either a usual care or a telemedicine group (Telemedicine plus usual care). Blood pressure,
weight, BMI, blood glucose and lipids, and physical activity will be measured at baseline
and at 6 months. We hypothesize that more subjects in the telemedicine group will achieve
goal blood pressure than in the control group. This will occur through increases in
knowledge, self-management, shared decision-making, and improved doctor-patient interaction.
Primary end- point will be the proportion of subjects who achieve goal blood pressure.
Secondary end-points will include:
Rate of self-monitoring, steps per day, weight, CVD knowledge, number of patients at
medication guidelines, and increased satisfaction with practice. Telemedicine utilization
will also be determined. We believe that telemedicine can facilitate PCC and reduce blood
pressure in a cost effective manner.
Basic demographic information will be obtained for each subject. The subject's primary care
physician's name, contact information, and specialty will be recorded.
All patients will have an initial medical history, physical examination, electrocardiogram,
blood studies, urinalysis, height, weight, and blood pressure measurement. Blood pressure
measurements will be obtained in the left arm of seated participants after 5 minutes of
quiet rest. A minimum of 3 BP readings will be taken. Systolic and diastolic BP will be
recorded. Waist circumference will be measured to the nearest 1 cm at the level of the iliac
crest while the subject is standing at minimal respiration. A fasting blood sample will be
obtained to determine serum cholesterol, LDL, HDL, triglycerides, creatinine, and glucose
levels. All participants will receive their values together with a brochure regarding
life-style modification (weight loss, smoking cessation, increased physical activity etc as
appropriate). The subjects will take a cardiovascular knowledge questionnaire and the CAHPS®
Clinician & Group Survey (CAHPS 2006).
Control Patients. Management of the patient's medical condition will be done by the
patient's primary care physician. No restriction will be placed on patient care or the
number of office visits with their physician(s). If a subject does not have a primary care
physician, we will arrange for the subject to be followed in a Temple based primary care
practice. At the final visit at 6 months, the control patients will be given the opportunity
to be followed by the telemedicine system.
Computer Training: Patients randomized to the telemedicine group will be trained on use of a
computer and the Internet and on how to access the Internet and web-site. Each patient will
be instructed on the details of Telemedicine system on a demonstration terminal in the
research center. At that time, the patient will be provided with login name and password to
gain access to the secure telemedicine site. The patient will make data entries with
coaching by the research team.
An important feature of the Telemedicine system will be telephone-based data entry and
communication. This will be added to the current Internet-based system using an Interactive
Voice Recognition (IVR) system, which will enable information transmitted via telephone or
Internet to be collected in the central database. Training on use of the IVR system (i.e.,
how to respond to prompts) will be incorporated into the patient training program for the
Internet.
The study patients randomized to the telemedicine group will be given a sphygmomanometer
with memory, a scale if needed, and a pedometer to count their steps per day. The
participants will receive instructions regarding proper use of these devices. Initially, the
subjects will wear a pedometer for 7 consecutive days and record the total number of steps
taken each day to obtain their baseline physical activity level. The participants will be
given recommendations for a gradual progression toward 10,000 steps/day. Ten thousand steps
per day are consistent with approximately 5 miles of walking per day. All participants will
be given a logbook and encouraged to record their measurements at least once a week (i.e.,
blood pressure, weight, average number of steps) over the course of the study. Life style
changes, increased exercise and weight loss, can make a significant impact on blood
pressure; a weight loss of as little as 10 lbs can reduce blood pressure.
Patients in the telemedicine group will also be provided with a toll-free number with which
to access the IVR system (a separate toll-free number will be provided to Hispanic patients
for a Spanish language IVR system). This system can be used as an alternate to the web-based
data entry screens available to all patients in the Internet arm. Basically, the patient
will dial the 800 number and a voice message will ask for the patient ID and password
(character strings entered via telephone keypad or spoken in sequence). The numerical values
for blood pressure, steps, weight, and cigarettes smoked can be entered via voice
recognition or by the keypad. Voice messages from the patient will also be permitted. These
will be spoken after a prompt, and will be designed to provide a short (i.e. 1 minute) voice
transmission that will be stored as a voice file (WAV) to the telemedicine system database.
Data entered via the IVR system will be inserted into the patient's personal health record
stored in the Telemedicine database.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |